VENUS REMEDIES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 382.6 INR | -0.05% |
|
+6.49% | -5.76% |
| Jun. 13 | Venus Remedies Bags Tender from UNICEF for Antibiotic Ceftriaxone | MT |
| May. 30 | Venus Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 61.28M | - | - | - | - | - | |
| 823B | ||||||
| 627B | ||||||
| 353B | - | - | - | - | ||
| 320B | ||||||
| 295B |
